Non-tuberculous, adenosine deaminase-positive lymphocytic pleural effusion : Consider immunoglobulin G4-related disease
Copyright: © 2020 SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES..
OBJECTIVE: Immunoglobulin G4-related disease (IgG4-RD) is a recently described systemic disorder. Pleural effusion is considered an uncommon manifestation of the disease. We describe a case series of patients with IgG4-RD and clinically significant pleural effusions.
METHODS: A retrospective analysis of patients with histologically proven IgG4-RD treated for pleural effusion in our clinic.
RESULTS: We identified 4 male patients with pleural effusion caused by IgG4-RD. The effusions were lymphocytic exudates, with especially high protein concentrations. All patients had hyperglobulinemia, elevated serum immunoglobulin G (IgG) levels and elevated levels subclasses IgG1 and IgG4. In two patients, levels of adenosine deaminase (ADA) were measured in the effusion and were elevated (309 and 108 IU/L). Tuberculosis was excluded in both cases by pleural biopsy. Involvement of other organs by IgG4-RD was the rule, especially thoracic lymphadenopathy which was prominent in all patients. In all cases, effusion responded to corticosteroids therapy. One patient developed radiological findings compatible with rounded atelectasis during remission.
CONCLUSIONS: IgG4-RD may cause an ADA-positive, lymphocytic exudate with a high protein concentration, characteristics resembling tuberculous effusion. Thoracic lymphadenopathy, hyperglobulinemia, and an increased total IgG, IgG1, IgG4 may suggest the diagnosis. Not previously described, IgG4-RD pleural inflammation may result in rounded atelectasis. (Sarcoidosis Vasc Diffuse Lung Dis 2020; 37 (2): 225-230).
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
---|---|
Enthalten in: |
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG - 37(2020), 2 vom: 16., Seite 225-230 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wand, Ori [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 03.11.2020 Date Revised 17.04.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.36141/svdld.v37i2.9098 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM316626767 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM316626767 | ||
003 | DE-627 | ||
005 | 20231225161509.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.36141/svdld.v37i2.9098 |2 doi | |
028 | 5 | 2 | |a pubmed24n1055.xml |
035 | |a (DE-627)NLM316626767 | ||
035 | |a (NLM)33093787 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wand, Ori |e verfasserin |4 aut | |
245 | 1 | 0 | |a Non-tuberculous, adenosine deaminase-positive lymphocytic pleural effusion |b Consider immunoglobulin G4-related disease |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.11.2020 | ||
500 | |a Date Revised 17.04.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright: © 2020 SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES. | ||
520 | |a OBJECTIVE: Immunoglobulin G4-related disease (IgG4-RD) is a recently described systemic disorder. Pleural effusion is considered an uncommon manifestation of the disease. We describe a case series of patients with IgG4-RD and clinically significant pleural effusions | ||
520 | |a METHODS: A retrospective analysis of patients with histologically proven IgG4-RD treated for pleural effusion in our clinic | ||
520 | |a RESULTS: We identified 4 male patients with pleural effusion caused by IgG4-RD. The effusions were lymphocytic exudates, with especially high protein concentrations. All patients had hyperglobulinemia, elevated serum immunoglobulin G (IgG) levels and elevated levels subclasses IgG1 and IgG4. In two patients, levels of adenosine deaminase (ADA) were measured in the effusion and were elevated (309 and 108 IU/L). Tuberculosis was excluded in both cases by pleural biopsy. Involvement of other organs by IgG4-RD was the rule, especially thoracic lymphadenopathy which was prominent in all patients. In all cases, effusion responded to corticosteroids therapy. One patient developed radiological findings compatible with rounded atelectasis during remission | ||
520 | |a CONCLUSIONS: IgG4-RD may cause an ADA-positive, lymphocytic exudate with a high protein concentration, characteristics resembling tuberculous effusion. Thoracic lymphadenopathy, hyperglobulinemia, and an increased total IgG, IgG1, IgG4 may suggest the diagnosis. Not previously described, IgG4-RD pleural inflammation may result in rounded atelectasis. (Sarcoidosis Vasc Diffuse Lung Dis 2020; 37 (2): 225-230) | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a ADA | |
650 | 4 | |a IgG4-related disease | |
650 | 4 | |a Immunoglobulin G4-related disease | |
650 | 4 | |a adenosine deaminase | |
650 | 4 | |a pleural effusion | |
650 | 4 | |a tuberculosis | |
650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
650 | 7 | |a Biomarkers |2 NLM | |
650 | 7 | |a ADA protein, human |2 NLM | |
650 | 7 | |a EC 3.5.4.4 |2 NLM | |
650 | 7 | |a Adenosine Deaminase |2 NLM | |
650 | 7 | |a EC 3.5.4.4 |2 NLM | |
700 | 1 | |a Fox, Benjamin D |e verfasserin |4 aut | |
700 | 1 | |a Shtraichman, Osnat |e verfasserin |4 aut | |
700 | 1 | |a Moreh-Rahav, Osnat |e verfasserin |4 aut | |
700 | 1 | |a Kramer, Mordechai R |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG |d 1996 |g 37(2020), 2 vom: 16., Seite 225-230 |w (DE-627)NLM088329399 |x 1124-0490 |7 nnns |
773 | 1 | 8 | |g volume:37 |g year:2020 |g number:2 |g day:16 |g pages:225-230 |
856 | 4 | 0 | |u http://dx.doi.org/10.36141/svdld.v37i2.9098 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 37 |j 2020 |e 2 |b 16 |h 225-230 |